InternationalUSRemember you can easily switch between MIP US and MIP International at any time

Government funding for research and development


The success of the high-tech sector in Israel has been driven by many factors, including the vast pool of talented scientists, engineers and researchers, a dynamic venture capital market, a genuine entrepreneurial spirit and advanced academic institutions and their increasingly fruitful collaboration with industry. In addition, the role of the Office of the Chief Scientist (OCS) of the Israeli Ministry of Industry, Trade and Labour and its many programmes, and the effect of the Law for the Encouragement of Industrial Research and Development, 1984, as amended (the Law), the implementation of which the OCS oversees, have also played an important role.

Among the Law's objectives is the creation of new employment opportunities in the technology industry in Israel through the encouragement of domestic research and development projects. The principal means by which these objectives are accomplished are financial grants for research and development made by the OCS to companies that...


Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of one week’s FREE access and become a Managing IP member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain 7 days FREE access when you register now.

Join here

profile

Managing IP

ManagingIP

ManagingIP profile

New EU General Court rules effective tomorrow http://t.co/asyjufhrs9 More info here ($/trial) http://t.co/0P9ESxFke4 Imp't for OHIM appeals

Jun 30 2015 03:51 ·  reply ·  retweet ·  favourite
ManagingIP profile

Why biotechs may prefer trade secrets to patents - @mdloney reports from #BIO2015 http://t.co/n7MyHccpab ($/trial) http://t.co/8cTcxSHj9M

Jun 30 2015 02:04 ·  reply ·  retweet ·  favourite
ManagingIP profile

SCOTUS denies Google appeal on Oracle suit http://t.co/MLfVgTKhuD via @WSJ Our topic page is here http://t.co/XGaB6XKcP6 #copyright

Jun 30 2015 02:00 ·  reply ·  retweet ·  favourite
More from the Managing IP blog


INTA Daily News 2015

Read this year's INTA Daily News - published daily by Managing IP direct from the INTA Annual Meeting in San Diego


June 2015

The fine line between abuse and fair use at the PTAB

Hedge fund manager Kyle Bass has outraged the pharma and biotech industries by seeking to invalidate their patents at the PTAB, with some observers linking his attacks to short-selling of company stocks. Michael Loney reports on a controversy that goes to the heart of the US patent system



Most read articles

Supplements